⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Consequences on the Gait Pattern of Patients With Distal Femur Megaprostheses

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Consequences on the Gait Pattern of Patients With Distal Femur Megaprostheses

Official Title: Consequences on the Gait Pattern of Patients With Distal Femur Megaprostheses Due to Tumor. Case-control Study.

Study ID: NCT06282198

Interventions

Study Description

Brief Summary: The primary aim of this study is to compare spatiotemporal gait parameters between participants with distal femur tumor prostheses and healthy individuals without prostheses.

Detailed Description: This study aims to investigate the gait symmetry index in participants with distal femur tumor prostheses in comparison to a control group. The hypothesis suggests that the symmetry index in participants will be lower than that of healthy controls. Additionally, the investigators aim to evaluate key spatiotemporal gait parameters between participants with distal femur tumor prostheses and healthy individuals, assess the impact of lower limb megaprostheses on participants' quality of life and function, study residual dysmetria among participants with distal femur megaprostheses, compare differences in gait patterns based on the type of femoral fixation used, and establish a correlation between spatiotemporal gait data and participants' functional capacity as assessed through various questionnaires. The assessment will include anamnesis and a complete clinical examination of tumoral participants with megaprostheses of the distal femur undergoing surgery at Hospital la Fe in Valencia, with a focus on joint mobility and muscle group strength. Subjective function will be evaluated using questionnaires such as the SF36 and MSTS (Musculoskeletal Tumor Society Score). Gait assessment will be conducted using a non-invasive portable device, the BTS G-sensor inertial sensor (BTS Bioengineering, Garbagnate Milanese, Italy), positioned at the S1 level to collect spatiotemporal gait data. These data will be analyzed in comparison to values obtained from healthy participants.

Eligibility

Minimum Age: 16 Years

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: Yes

Locations

Universidad CEU Cardenal Herrera, Valencia, , Spain

Contact Details

Name: Juan F Lisón, PhD

Affiliation: Cardenal Herrera University

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: